Know the Latest About COVID-19 MAbs and Remdesivir
Questions are popping up about changes with COVID-19 monoclonal antibodies (MAbs) and remdesivir.
Treatment. If oral nirmatrelvir/ritonavir (Paxlovid) is not an option, use the IV MAb sotrovimab for mild to moderate COVID-19.
Consider it for OUTpatients positive for COVID-19 who are at high risk of severe illness (diabetes, etc)...regardless of vaccination status.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote